Biotech Values

[Cmed123]

If this breaks the $17 pricing this may be single digits Pre-launch...
I understand DD assertion that this doesn’t have usual constraints of insurance reimbursement
And formularies etc, but nevertheless I think it could be a slow uptake against the current champion..
Wall Street is not patient and shorting the launch mentality can still wreck havoc on stock while
waiting to assemble a quality sales team to go against entrenched competitor...